Skip to main content
Caplight Logo









Marisma Biomed

Marisma Biomed

Private
SpainConsumer & Commercehttps://marismabiomed.com/en

Company Overview

Marisma Biomed operates in Consumer & Commerce and is based in Spain.

Marisma Biomed is a bio-food-tech company that develops functional foods and dietary supplements derived from natural marshland ingredients like salicornia to support cardiovascular health.

Sector

Consumer & Commerce

Verticals

Biotechnology, D2C Brands, E-commerce

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Marisma Biomed Comparables

Compare Marisma Biomed with similar companies based on industry and business-model similarity.

Marisma Biomed comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Marsh Foods
84%
Horta dos Peixinhos
84%
Salina Greens
83%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Marisma Biomed Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for Marisma Biomed. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Joan Montaner

Co-founder & CEO

Founding Team

Sara Montaner Perea

Chief Operating Officer, Diseñador gráfico

Executive Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 16, 2026

    Monthly visitors increased 44% MoM, reaching 3.8K.

  • Nov 8, 2025

    Monthly visitors grew 174% MoM, reaching 4K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Marisma Biomed Filings

Explore SEC and related filing metadata, where available.

Marisma Biomed filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Marisma Biomed's valuation, stock price, and market status.

Is Marisma Biomed a public or private company?

Marisma Biomed is a private company.

What is the current stock price of Marisma Biomed?

Marisma Biomed is a private company, so its shares have no public market price. Caplight tracks Marisma Biomed's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Marisma Biomed worth (valuation)?

Valuation information for Marisma Biomed is not publicly available.

Can I buy Marisma Biomed stock?

Marisma Biomed shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Marisma Biomed's last funding round?

Funding round information for Marisma Biomed is not publicly available.

Who are the main investors in Marisma Biomed?

Investor information for Marisma Biomed is not publicly disclosed.

Will Marisma Biomed IPO soon?

No public IPO plans have been announced for Marisma Biomed.

How can I track Marisma Biomed secondary market activity?

Caplight tracks bids, offers, and trades in Marisma Biomed's shares on secondary markets.

Firmographic Details

HeadquartersSpain
Employee Range3
Year FoundedN/A
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?